Compare LAB & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAB | NCA |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | 389 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.3M | 318.5M |
| IPO Year | 2008 | 1995 |
| Metric | LAB | NCA |
|---|---|---|
| Price | $0.99 | $9.44 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 54.8K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.92% |
| EPS Growth | ★ 61.54 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $101,937,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $2.99 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.87 | $8.33 |
| 52 Week High | $1.72 | $9.80 |
| Indicator | LAB | NCA |
|---|---|---|
| Relative Strength Index (RSI) | 54.90 | 49.67 |
| Support Level | $0.92 | $9.18 |
| Resistance Level | $1.02 | $9.54 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 72.33 | 41.38 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.